Fundz

Sudo Biosciences reported raising $53.3 Million in an initial SEC Form D filing, from an offering of $141 Million

PRIVATEDec 28, 2023$53.3M of $141M raised

Amount Raised

$53.3 Million

$53.3 Million sold, per SEC Form D (first sale Dec 15, 2023)

Round Type

Venture

CarmelBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnology Research

Quick answer

Sudo Biosciences raised $53.3 Million in a funding round, dated December 15, 2023. Sudo Biosciences is based in Carmel, Indiana, United States.

How much did Sudo Biosciences raise?
Sudo Biosciences raised $53.3 Million in a funding round on December 15, 2023.
What does Sudo Biosciences do?
Sudo Biosciences is a clinical-stage biopharmaceutical company developing next-generation TYK2 inhibitors to transform the treatment of immune-mediated diseases.
Where is Sudo Biosciences based and how big is it?
Sudo Biosciences is based in Carmel, Indiana, United States. Fundz records about 24 employees.
Who are the decision-makers at Sudo Biosciences?
Fundz holds 1 contact at Sudo Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Sudo Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Liquidia raised $100M (Funding Round) on January 4, 2024.
  • OnCusp Therapeutics raised $100M (Series A) on January 4, 2024.
  • Os Therapies raised $700K on December 8, 2023.
  • Cartesian Therapeutics, Inc. raised $60M on November 13, 2023.
  • Forward Therapeutics raised $50M (Series A) on November 8, 2023.
  • Attralus raised $56M on January 26, 2024.

Who to call at Sudo Biosciences, and when

A new round usually means Sudo Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sudo Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sudo Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sudo Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sudo Biosciences

Location

Carmel, Indiana, United States

About

Sudo Biosciences is a clinical-stage biopharmaceutical company developing next-generation TYK2 inhibitors to transform the treatment of immune-mediated diseases. Its pipeline includes a potential first- and best-in-class, once-daily oral, brain-penetrant candidate for multiple sclerosis and other neuroinflammatory conditions, as well as a topical candidate for dermatologic diseases. Based in Carmel, IN and London, U.K., Sudo is advancing novel medicines designed to improve patient lives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sudo Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Sudo Biosciences's next move

See what Strategic adds

Sudo Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.